Takeda Pharmaceuticals Australia Pty Ltd has a s.394 (Application for unfair dismissal remedy) it needs to rationalise before Deputy President Boyce in chambers in Sydney today (Havier).
FEATURED
Hospitals morphing into wellness and health precincts
Developers release plans for latest bayside living proposal
Technology will help urban spaces adapt in an ever-changing world
New funding agency to ‘supercharge’ community housing providers
Drug company deal delivers hope for dementia patients
Proactive alliances among stakeholders can lead to assisted living departments
INNOVATION
